Zydus Lifesciences Ltd 2012 AR2
The report highlights Cadila Healthcare Limited's (Zydus) strategic launch of its 'Beyond the Billion' growth strategy for 2015, driven by the pillars of Value Creation, Innovation, Collaboration, and Accountability (VICA). Key operational achievements include the acquisition of Biochem Pharma and Nesher Pharmaceuticals, expanding its presence in India and the US. In sustainability, the company advanced its environmental initiatives, implementing a first-of-its-kind Ceramic Ultrafiltration System for effluent treatment in India and expanding rainwater harvesting. Additionally, Zydus continued its community development programs under 'Zydus Srishti,' focusing on healthcare, education, and research.
Company: Zydus Lifesciences Ltd
Sector: Health Care
Country: India
Year: 2012
Type: AR2
Pages: 92
Zydus Lifesciences Ltd
Annual Report
The report highlights Cadila Healthcare Limited's (Zydus) strategic launch of its 'Beyond the Billion' growth strategy for 2015, driven by the pillars of Value Creation, Innovation, Collaboration, and Accountability (VICA). Key operational achievements include the acquisition of Biochem Pharma and Nesher Pharmaceuticals, expanding its presence in India and the US. In sustainability, the company advanced its environmental initiatives, implementing a first-of-its-kind Ceramic Ultrafiltration System for effluent treatment in India and expanding rainwater harvesting. Additionally, Zydus continued its community development programs under 'Zydus Srishti,' focusing on healthcare, education, and research.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2012
Reporting Period
Apr 1, 2011 - Mar 31, 2012
Fiscal Year
2012
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees